F037 Follicular Rescue in Scarring Alopecias: Treating to Halt Disease Progression and Grow Hair
DESCRIPTION
This course will help the dermatologist understand the indications for treating scarring alopecias. The faculty will discuss therapeutic approaches and emerging literature on lichen planopilaris, frontal fibrosing alopecia, and central centrifugal cicatricial alopecia. Dermatoscopic and pathologic cues to viable hair growth in the scarring scalp will be covered. Emerging treatments as well as an approach to healthy hair care practices will be covered. Role of aesthetic procedures, like PRP, laser and microneedling as well as indications for adding treatments like oral minoxidil for adjunct treatment, will also be discussed.
LEARNING OBJECTIVES
Describe the concept of follicular rescue in scarring forms of hair loss
Demonstrate the signs of treatable scarring alopecias using dermoscopic and pathologic cues
Discuss the therapeutic ladder of treatments to treat scarring alopecias with familiar and new therapies
SCHEDULE
3:30 PM
Introduction
Crystal Aguh, MD, FAAD
3:35 PM
Metabolic Influences on Scalp Fibrosis
Lindsey Bordone, MD, FAAD
3:50 PM
Updates on our Understanding of CCCA
Crystal Aguh, MD, FAAD
4:05 PM
Updates on FFA Pathogenesis and Risk Factors
Kristen Irene Lo Sicco, MD, FAAD
4:20 PM
The Emerging Role of JAK Inhibitors in Scarring Alopecia
Maryanne Makredes Senna, MD, FAAD
4:35 PM
Approach to other Scarring Alopecias: DLE, Dissecting Cellulitis, and Folliculitis Decalvans
4:50 PM
Cosmetic and Procedural interventions for scarring alopecia
Ronda S. Farah, MD, FAAD
5:05 PM
Faculty Q&A
DIRECTOR
Crystal Aguh, MD, FAAD
Johns Hopkins School of Medicine
SPEAKERS
Lindsey Bordone, MD, FAAD
University of Arizona College of Medicine, Tucson, AZ
Ronda S. Farah, MD, FAAD
Kristen Irene Lo Sicco, MD, FAAD
Maryanne Makredes Senna, MD, FAAD
DISCLOSURES
Crystal Aguh, MD, FAAD
CP Skin Health – Advisory Board(Honoraria); Eli Lilly and Company – Consultant(Fees); Johnson & Johnson – Other(Residency/Fellowship Program Funding); Pfizer Inc. – Consultant(Fees); Procter & Gamble Company – Consultant (1099 relationship)(Fees); UpToDate, Inc – Other(Fees); Veradermics – Advisory Board(Fees);
Lindsey Bordone, MD, FAAD
No financial relationships exist with ineligible companies.
Ronda S. Farah, MD, FAAD
American Academy of Dermatology – Other(Grants/Research Funding); Arcutis, Inc. – Investigator(Grants/Research Funding); ASLAN Pharmaceuticals – Investigator(Grants/Research Funding); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Early Sullivan Wright Gizer & McRae LLP – Consultant (1099 relationship)(Fees); Eli Lilly – Investigator(Grants/Research Funding); Incyte – Investigator(Grants/Research Funding); Intrepid Therapeutics, Inc. – Investigator(Grants/Research Funding); Lumenis Be Ltd. – Consultant (1099 relationship)(Fees); Novartis – Advisory Board(Fees); Pfizer – Investigator(Grants/Research Funding); Pfizer Inc. – Stockholder(No Compensation Received), Stockholder Public Company(No Compensation Received); Sun Pharma Advanced Research Company (SPARC) – Advisory Board(Honoraria); Technoderma Medicines – Investigator(Grants/Research Funding); Veradermics – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
Kristen Irene Lo Sicco, MD, FAAD
AQUIS – Consultant (1099 relationship)(Fees); Eli Lilly – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Fees), Investigator(Grants/Research Funding); Priovant Therapeutics – Consultant (1099 relationship)(Fees); RegenLab – Investigator(Grants/Research Funding); Veradermics – Consultant (1099 relationship)(Fees);
Maryanne Makredes Senna, MD, FAAD
AbbVie – Advisory Board(Fees); American Hair Research Society – Board of Directors(No Compensation Received); Cicatricial Alopecia Research Foundation – Board of Directors(No Compensation Received); CoreEvitas, LLC – Advisory Board(Fees), Investigator(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Fees); GLife – Advisory Board(Stock Options); Inmagene – Investigator(Grants/Research Funding); Inmagene Biopharmaceuticals – Consultant (1099 relationship)(Fees); Kintor Pharmaceutical Limited – Consultant (1099 relationship)(Fees); L'Oreal USA Inc. – Consultant (1099 relationship)(Fees); Leo Pharma Inc – Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Fees), Speaker(Fees); Priovant Therapeutics – Advisory Board(Fees), Investigator(Grants/Research Funding); Q32 Bio Inc. – Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees); Veradermics – Advisory Board(Fees), Advisory Board(Stock);